A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
Clinical trial NCT04041284 · COMPLETED
Trial details
- NCT number
- NCT04041284
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-13
- Primary completion
- 2022-08-31
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.